At the end of this experiment, the average tumor mass after combination therapy was 0.33 ± 0.11 g, compared to 0.65 ± 0.20 g (for TRAIL) and 0.69 ± 0.13 g (ZIR700-mediated PDT) after monotherapy. The gene discussed is TNFSF10; the disease is neoplasm.